A decade after the vaccine was introduced, research shows dramatic success. Australian scientist Ian Frazer says his collaborator Jian Zhou will be ‘vindicated’ when it becomes available in the Chinese market this year
The virologist and cancer researcher Dr Jian Zhou had an important goal after creating a vaccine for the cancer-causing human papillomavirus in a Queensland laboratory.
He wanted to see the vaccine made widely available in his home country of China, which today accounts for more than 28% of the world’s cervical cancer cases. Cervical cancer is also the second most common cancer in Chinese women aged between 15 and 44.
Link : HPV infection rates plummet after vaccine with China the next frontier